# $fbio ZYCUBO has been approved by the FDA, but concerns are rising about the missing $150M PRV, potentially invalidating previous investment theses. ### About $fbio $FBIO refers to a social media platform and its associated community, likely focused on biotechnology and pharmaceutical discussions. ### Top $fbio Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "January [----] Biotech PDUFA Update 📡 Whats on the FDA radar Recent Outcomes: $ATRA tab-cel (EBV+ PTLD) CRL $TVTX FILSPARI (FSGS) Extended 4/13/26 $FBIO ZYCUBO (copper histidinate) Approved Pending FDA Decisions: Jan [--] $AQST Anaphylm (Anaphylaxis) No AdCom Jan [--] $PHAR Joenja Pediatric APDS Priority Review See attached graphic for full January PDUFA calendar. https://twitter.com/i/web/status/2012268787907838407 https://twitter.com/i/web/status/2012268787907838407" [X Link](https://x.com/BiopharmIQ/status/2012268787907838407) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-01-16T21:00Z 28.8K followers, 48.4K engagements "🧵 $FBIO: I Was Wrong. The thesis is dead. I missed a critical regulatory kill-switch. ZYCUBO is approved. But the $150M PRV is missing. Its never coming. I built a thesis on "Free Money." I walked into a Statutory Trap. Here is the autopsy. 👇 (1/8)" [X Link](https://x.com/BiotechAutist/status/2010967038856958059) [@BiotechAutist](/creator/x/BiotechAutist) 2026-01-13T06:47Z [----] followers, 10.7K engagements "January [----] Biotech PDUFA Pulse: 📡 Whats on the FDA Radar Jan [--] $ATRA tab-cel (EBV+ PTLD) Priority Review Jan [--] $TVTX FILSPARI (FSGS) no AdCom Jan [--] $FBIO CUTX-101 (Menkes) Class [--] resubmission Jan [--] $AQST Anaphylm (anaphylaxis) no AdCom Jan [--] $PHAR Joenja pediatric APDS Priority Review See attached graphic for the full January PDUFA calendar. https://twitter.com/i/web/status/2006357977909936391 https://twitter.com/i/web/status/2006357977909936391" [X Link](https://x.com/BiopharmIQ/status/2006357977909936391) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-12-31T13:33Z 28.8K followers, 103.7K engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
ZYCUBO has been approved by the FDA, but concerns are rising about the missing $150M PRV, potentially invalidating previous investment theses.
$FBIO refers to a social media platform and its associated community, likely focused on biotechnology and pharmaceutical discussions.
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"January [----] Biotech PDUFA Update 📡 Whats on the FDA radar Recent Outcomes: $ATRA tab-cel (EBV+ PTLD) CRL $TVTX FILSPARI (FSGS) Extended 4/13/26 $FBIO ZYCUBO (copper histidinate) Approved Pending FDA Decisions: Jan [--] $AQST Anaphylm (Anaphylaxis) No AdCom Jan [--] $PHAR Joenja Pediatric APDS Priority Review See attached graphic for full January PDUFA calendar. https://twitter.com/i/web/status/2012268787907838407 https://twitter.com/i/web/status/2012268787907838407"
X Link @BiopharmIQ 2026-01-16T21:00Z 28.8K followers, 48.4K engagements
"🧵 $FBIO: I Was Wrong. The thesis is dead. I missed a critical regulatory kill-switch. ZYCUBO is approved. But the $150M PRV is missing. Its never coming. I built a thesis on "Free Money." I walked into a Statutory Trap. Here is the autopsy. 👇 (1/8)"
X Link @BiotechAutist 2026-01-13T06:47Z [----] followers, 10.7K engagements
"January [----] Biotech PDUFA Pulse: 📡 Whats on the FDA Radar Jan [--] $ATRA tab-cel (EBV+ PTLD) Priority Review Jan [--] $TVTX FILSPARI (FSGS) no AdCom Jan [--] $FBIO CUTX-101 (Menkes) Class [--] resubmission Jan [--] $AQST Anaphylm (anaphylaxis) no AdCom Jan [--] $PHAR Joenja pediatric APDS Priority Review See attached graphic for the full January PDUFA calendar. https://twitter.com/i/web/status/2006357977909936391 https://twitter.com/i/web/status/2006357977909936391"
X Link @BiopharmIQ 2025-12-31T13:33Z 28.8K followers, 103.7K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$fbio